Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values
Authors:
Open Access
- 28 January 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (1) , e16470
Abstract
This study was designed to examine the relationship between shortened activated partial thromboplastin time (APTT) and increased fibrinogen values with diabetes mellitus. APTT, prothrombin time (PT), fibrinogen, fasting plasma glucose (FPG) and glycosylated hemoglobin A1c (HbA1c) levels were measured in 1,300 patients. Patients were divided into three groups according to their HbA1c and FPG levels. When participants were grouped according to their HbA1c levels, we found significantly shorter APTT values (26.9±5.6 s) and increased fibrinogen levels (3.1, 1.9–6.3 g/L) in the diabetes group when compared with the other two groups. When participants were grouped according to their FPG levels, we found significantly shorter APTT values (26.9±6.2 s) and increased fibrinogen levels (3.1, 1.8–6.2 g/L) in the diabetes group when compared with the euglycemic group. Shorter APTT and increased fibrinogen levels might be useful hemostatic markers in patients with diabetes and in patients at high risk for diabetes.Keywords
This publication has 29 references indexed in Scilit:
- A laboratory evaluation into the short activated partial thromboplastin timeBlood Coagulation & Fibrinolysis, 2010
- Prothrombin Time and Partial Thromboplastin Time Assay ConsiderationsClinics In Laboratory Medicine, 2009
- Epidemiological association between fasting plasma glucose and shortened APTTClinical Biochemistry, 2009
- The activated partial thromboplastin time in early diagnosis of myocardial infarctionBlood Coagulation & Fibrinolysis, 2001
- Diabetes mellitusJournal of Diabetes and its Complications, 2001
- Partial Thromboplastin TimeArchives of internal medicine (1960), 1999
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 1998
- Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: A prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitusAmerican Journal of Hematology, 1997
- Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospectsDiabetologia, 1993
- Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experienceAmerican Heart Journal, 1990